Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

Genetics: Expression signature identifies high-risk patients A gene expression signature identifies breast cancer patients who do poorly after endocrine therapy and might benefit from extra treatment. A team led by John Bartlett and Paul Boutros from the Ontario Institute for Cancer Research in Toro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jane Bayani, Cindy Q. Yao, Mary Anne Quintayo, Fu Yan, Syed Haider, Alister D’Costa, Cassandra L. Brookes, Cornelis J. H. van de Velde, Annette Hasenburg, Dirk G. Kieback, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Daniel Rea, Paul C. Boutros, John M. S. Bartlett
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/e8e3e37c9ac342eb853c51e4f6f7efcc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/e8e3e37c9ac342eb853c51e4f6f7efcc

Ejemplares similares